Clinical Trials Directory

Trials / Completed

CompletedNCT03485781

Propofol-induced EEG Changes in Hypoxic Brain Injury

Assessment of Hypoxic Brain Injury by Analyzing Propofol-induced EEG Changes

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
University of Oulu · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

PROPEA3 is a prospective observational study investigating the recovery of propofol-induced EEG slow-wave activity and its association with neurological outcome after cardiac arrest.

Detailed description

PROPEA3 is a prospective observational study investigating the recovery of propofol-induced EEG slow-wave activity and its association with neurological outcome after cardiac arrest. Comatose adult patients admitted to intensive care unit (ICU) after cardiac arrest are included. Patients with previous neurological disease expected to affect substantially EEG are excluded. The patients' relatives are asked for an informed written consent to participate. In the intensive care, the patients are sedated using continuous infusion of propofol while receiving temperature management/hypothermia treatment following the ICUs' common practice. EEG is recorded continuously from the admission to the ICU until 48 hours from the cardiac arrest. EEG slow-wave activity is determined offline by calculating the low-frequency (\<1 Hz) power from the signal. The neurological recovery of the patients is defined 6 months after cardiac arrest from patient documents and/or by phone call to the patient/relative using Cerebral Performance Category. After the follow-up period patient or the relative is also asked to fill a survey (SF-36) to estimate the health and quality of life.

Conditions

Timeline

Start date
2017-10-12
Primary completion
2019-07-10
Completion
2019-07-10
First posted
2018-04-02
Last updated
2020-03-25

Locations

2 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT03485781. Inclusion in this directory is not an endorsement.